Furthermore, moderate, but not bridging fibrosis enhanced the expression of NFKBIZ, suggesting that NFKBIZ plays a role in the early stage of NAFLD. The gene discussed is NFKBIZ; the disease is metabolic dysfunction-associated steatotic liver disease.